The total return over the past 12 months is -36.75% vs. +16.94% for the S&P 500. So far it's up -32.79% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (36.75%) | (15.57%) | (4.94%) | (6.46%) | +9.93% | N/A |
| Total Return CAGR | (36.75%) | (15.57%) | (4.94%) | (6.46%) | +9.93% | N/A |
| Revenue CAGR | (2.36%) | +6.38% | +6.36% | +5.32% | +36.53% | N/A |
| Net Income CAGR | (80.61%) | N/A | N/A | (12.27%) | N/A | N/A |
| EPS CAGR | (81.88%) | N/A | N/A | +1.66% | N/A | N/A |
| Free Cash Flow CAGR | (22.04%) | N/A | N/A | +14.05% | N/A | N/A |
| Operating Cash Flow CAGR | (20.60%) | N/A | N/A | +9.89% | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
MiMedx Group, Inc. (MDXG)
| Year | Start price | End price | MDXG Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $6.77 | $4.55 | (32.79%) | +14.51% | (47.30%) |
| 2025 | $9.62 | $6.77 | (29.63%) | +17.72% | (47.35%) |
| 2024 | $8.77 | $9.62 | +9.69% | +24.89% | (15.20%) |
| 2023 | $2.78 | $8.77 | +215.47% | +26.19% | +189.28% |
| 2022 | $6.04 | $2.78 | (53.97%) | (18.17%) | (35.80%) |
| 2021 | $9.08 | $6.04 | (33.48%) | +28.74% | (62.22%) |
| 2020 | $7.58 | $9.08 | +19.79% | +18.37% | +1.42% |
| 2019 | $1.79 | $7.58 | +323.46% | +31.22% | +292.24% |
| 2018 | $12.61 | $1.79 | (85.80%) | (4.56%) | (81.24%) |
| 2017 | $8.86 | $12.61 | +42.33% | +21.70% | +20.63% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
